Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ ANLEIHEN-Woche #KW34 – 2025: Energiekontor, JDC, The Platform Group, Aream, LEEF, Dt. Rohstoff,... (Anleihen-Finder) +++ PLATFORM GROUP Aktie +4,84%

News zum Sektor Gesundheit aus Asien

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 100 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1576 Aktien zum Sektor Gesundheit bekannt.
 
22.08.25 - 15:24
Opening Bell: Wall Street vor Powell-Rede freundlich; Walmart, Unitedhealth, Nio, Xpeng, First Solar im Fokus (Der Aktionaer)
 
Wenige Stunden vor der Rede von US-Notenbankchef Jerome Powell am Freitag sind die Anleger in New York vorsichtig optimistisch. Es herrscht die Hoffnung, dass Powell positive Hinweise in Richtung einer Zinssenkung auf der Sitzung Mitte September geben wird....
22.08.25 - 13:00
Zacks.com featured highlights StoneCo, CVS Health, Integer and USANA Health Sciences (Zacks)
 
StoneCo, CVS Health, Integer and USANA Health Sciences stand out as low P/CF value plays with solid growth forecasts in a volatile market....
22.08.25 - 12:15
Antengene Announces 2025 Interim Financial Results Highlighting Encouraging Data from Mid/Late-Stage Clinical Programs and Its Innovative TCE Technology Platform (PR Newswire)
 
The Phase I/II CLINCH study of ATG-022 (CLDN18.2 antibody-drug conjugate) demonstrated promising results, showing robust clinical efficacy and a favorable safety profile in patients with gastric/gastroesophageal junction adenocarcinoma across high, low, and ultra-low CLDN18.2 expression......
22.08.25 - 10:15
Full-day Takeaway: HSI Closes at 25,339, Up 234 pts; HSTI Closes at 5,647, Up 149 pts; XPENG Up over 13%; TENCENT, SINO BIOPHARM, CHOW TAI FOOK, CHINA MOBILE, HUA HONG SEMI Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 234 pts or 0.9% to 25,339. HSTI rose 149 pts or 2.7% to 5,647. HSCEI gained 105 pts or 1.2% to 9,079. Market turnover reached $285.58 billion.Active Heavyweights:XIAOMI (01810.HK) closed at $52.55, up 2.3%BABA (09988.HK) closed at $118, up 2%HKEX (00388.HK) closed at $448, up 1.3%TENCENT (00700.HK) closed at $......
22.08.25 - 07:30
CSPC PHARMA Craters 3%+ as Interim NP Falls 15.6% w/ Less DPS (AAStocks)
 
CSPC PHARMA (01093.HK) closed up 0.38% at midday, but slipped in the afternoon after announcing its interim results. It last printed at $10.16, down 3.15%, with a trading volume of 59.2772 million shares, involving $617 million.CSPC PHARMA's interim turnover was RMB13.273 billion, down 18.5% YoY. Net profit amounted to RMB2.......
22.08.25 - 06:45
Results: CSPC PHARMA Interim NP Drops 15.6% to RMB2.55B; Interim DPS Reduced to $14 Cents (AAStocks)
 
CSPC PHARMA (01093.HK) announced its interim results for the period ended June 2025. Turnover declined by 18.5% YoY to RMB13.273 billion. Net profit amounted to RMB2.548 billion, down 15.6% YoY, with an EPS of RMB22.29 cents. An interim DPS of $14 cents was declared, compared to $16 cents in the corresponding period of 2024.~AAS......
22.08.25 - 06:15
Midday Takeaway: HSI Closes Midday at 25,184, Up 80 pts; HSTI Closes Midday at 5,586, Up 88 pts; XPENG Up over 10%; TENCENT, SINO BIOPHARM, CHOW TAI FOOK, HUA HONG SEMI, AKESO Hit New Highs (AAStocks)
 
At midday close, HSI rose 80 pts or 0.3% to 25,184. HSTI rose 88 pts or 1.6% to 5,586. HSCEI gained 47 pts or 0.5% to 9,022.Active Heavyweights:XIAOMI (01810.HK) closed at $52.35, up 1.9%TENCENT (00700.HK) closed at $601.5, up 1.4%, hitting new highBABA (09988.HK) closed at $117.2, up 1.3%MEITUAN (03690.HK) closed at $116.6, dow......
22.08.25 - 05:30
Research: M Stanley Lists Latest HK Focus List (Table) (AAStocks)
 
StockAlibaba Group Holding (BABA.US)CHINA RES POWER (00836.HK)YANGTZE POWER (600900.SH)CATL (300750.SZ)* DUALITYBIO-B (09606.HK)ESPRESSIF (688018.SH)HKT-SS (06823.HK)HKEX (00388.HK)NARI (600406.SH)PETROCHINA (00857.HK)PICC P&C (02328.HK)SPRING AIRLINES (601021.SH)SUNNY OPTICAL (02382.HK)TENCENT (00700.HK)ZIJIN MINING (02899.......
22.08.25 - 01:12
Pop Mart, Health-Care Stocks Lead Hang Seng Index Contenders (Bloomberg)
 
Hang Seng Indexes Co. is likely adding Labubu doll-maker Pop Mart International Group Ltd. and several health-care firms to its Hong Kong stock benchmark, analysts say....
21.08.25 - 23:01
Angelalign Technology bestreitet Patentverletzung und kündigt energische Verteidigung an (News Aktuell)
 
Angel Aligner: San Clemente, Kalifornien (ots/PRNewswire) - Angelalign Technology Inc. (6699.HK) („Angel") weist die Vorwürfe der Patentverletzung durch Align Technology Inc. (ALGN) entschieden zurück und verspricht eine energische Verteidigung. „Angel ......
21.08.25 - 18:54
Brii Biosciences reports 1H results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.08.25 - 18:39
Ascentage Pharma Group International GAAP EPS of -$0.24, revenue of $32.6M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.08.25 - 18:15
4 Value Stocks Every Investor Should Hold in Volatile Times (Zacks)
 
StoneCo, CVS, Integer Holdings and USANA emerge as attractive value stocks with low cash-flow ratios and solid growth outlooks....
21.08.25 - 16:45
Value Investing: 5 Undervalued Stocks Worth Adding to Your Portfolio (Zacks)
 
StoneCo, CVS Health, KT, KB Financial and USANA Health stand out as undervalued picks with low P/B ratios and solid growth prospects....
21.08.25 - 12:06
Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results (PR Newswire)
 
Multiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic soralimixin Strong Cash Position to Pursue New Discovery Opportunities and Partnership Strategy Conference Calls......
21.08.25 - 11:00
Research: BOCI Hikes WUXI BIO TP to $31; Profitability Recovery w/ Steady Order Momentum (AAStocks)
 
WUXI BIO (02269.HK) delivered solid 1H25 results, with accelerated revenue growth and notable recovery in profitability, BOC International stated. The backlog of orders steadily expanded, bolstering interim revenue visibility. However, excluding the XDC, the core biologics growth remained moderate, and high capex along with capa......
21.08.25 - 10:48
Japan′s Daiichi Sankyo Shares Drop After Discounted Block Trades (Bloomberg)
 
Daiichi Sankyo Co. shares dropped the most in three months following a series of discounted block trades in the Japanese pharmaceutical company....
21.08.25 - 09:18
Qlife together with Birmingham Women′s and Children′s NHS Foundation Trust achieve positive results for its rare disease self-test PHE product (Cision)
 
Gothenburg, Sweden - Qlife Holding AB (“Qlife” or the “Company”) announces that it has finalized its clinical study for children and young people under 18 years of age. The study was focused on the self-test at-home aspect and the comparison of data to standard of care methodology DBS-cards (Dried Blood Spots). The study and the enrollment were completed under the leadership of Professor Anita MacDonald, Professor in Dietetics at Birmingham Women's and Children's NHS Foundation Trust. Summary of results: · High concordance between Egoo PHE Test results and the Dry Blood Spot (DBS)...
21.08.25 - 08:18
CanSino Says Close to Break Even This Year (Bloomberg)
 
Xuefeng Yu, co-Founder, chairman and CEO of Chinese vaccine maker CanSino Biologics, says he expects the company's newly approved pneumococcal vaccine to help boost revenue next in 2026. Still, he adds that the firm is on track to reach its breakeven target this year. He speaks exclusively with David Ingles and Yvonne Man on "Bloomberg: The China Show." (Source: Bloomberg)...
21.08.25 - 07:15
Research: Daiwa Lifts WUXI BIO's TP to HKD35.5; Growth in RDM Segments Strong (AAStocks)
 
WUXI BIO (02269.HK)'s 1H25 results met expectations, with strong growth in its revenue, GPM, and backlog orders, Daiwa wrote in its research report.The visibility for the company's research-development-manufacturing (RDM) segments is expected to be high in 2H25, while its GPM will continue improving.Daiwa reiterated a Bu......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Politiker verschweigt oft auch das, was er nicht weiß. - Dr. Fritz P. Rinnhofer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!